Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients (Q33367321)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients |
scientific article |
Statements
1 reference
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients (English)
1 reference
Gerardo Botti
1 reference
Maurizio Di Bonito
1 reference
Massimiliano D'Aiuto
1 reference
Paolo Vallone
1 reference
Renato Thomas
1 reference
Giuseppe Frasci
1 reference
Giuseppe D'Aiuto
1 reference
Pasquale Comella
1 reference
Liliana Lapenta
1 reference
Vincenzo De Rosa
1 reference
Roberta D'Aniello
1 reference
Renato Giordano
1 reference
Giuseppe Comella
1 reference
12 July 2005
1 reference
1 reference
68
1 reference
4-6
1 reference
391-397
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference